Contact us
Request a Quote

Toda Covdiag X – Triplex

Infectious Diseases

3-in-1 rapid test: Covid-19, Influenza A&B, and RSV

Toda Covdiag X Triplex est un test de diagnostic rapide pour la détection qualitative simultanée des antigènes du COVID-19 et des virus de la grippe de type A&B, et du virus RSV dans des échantillons d’écouvillons nasopharyngés.

  • Influenza A&B
  • SARS-CoV-2 (COVID-19)
  • RSV
  • Interpretation time
    15 minutes
  • Sampling
    Nasopharyngeal swab

A rapid, accurate, and convenient test

Les avantages du Toda Covdiag X- Triplex.

MULTI-DETECTION

Simultaneous analysis of COVID-19, Influenza A & B viruses, and RSV in a single test, enabling differential diagnosis.

CONVENIENT

Individual, ready-to-use buffer vials and a single-use diluent included for each test, limiting contamination risks.

EFFICIENT

Contributes to appropriate interventions and optimized care.

ACCURATE, SENSITIVE, AND SPECIFIC

See performance table below. 

Performance

PERFORMANCE COVID-19 INFLUENZA A INFLUENZA B RSV
Sensitivity 96.7% 95.3% 91.5% 90.0%
Specificity 99.5% 99.5% 99.6% 99.0%
Accuracy 98.5% 99,0% 98.8% 98.4%

An accurate test starts with proper technique

Découvrez en 5 étapes simples comment utiliser le Toda Covdiag X-Triplex.  

This test is intended for use by healthcare professionals only.

Practical information

Tous les coffrets Toda Covdiag X-Triplex contiennent :

  • 20 tests au format cassette
  • 20 écouvillons
  • 20 flacons de diluant
  • 1 notice détaillée

References

  • Box of 20 tests: 0803008

The test should be stored at room temperature (between +2 and +30 °C).

Helpful documents

Catalog & product sheet

Infectious Diseases Catalogue

Fiche produit Toda Covdiag X-Triplex

Download

For any additional information requests

"*" indicates required fields

Last Name*
Email*
Do you have a question or a specific need? Our team is here to help.
GDPR

Learn more

1. Why is it important to differentiate between COVID-19, influenza, and bronchiolitis?

These three infections share similar symptoms (cough, fever, respiratory distress), making clinical diagnosis alone challenging. However, medical management, isolation protocols, treatments, and recommendations vary depending on the causative virus.
Therefore, an accurate diagnosis enables:

  • Tailored therapeutic guidance (antivirals, antibiotics to avoid, hospitalization status)
  • Limiting transmission, particularly in hospital settings, nurseries, or nursing homes (EHPAD)
  • Reassuring or alerting patients based on the diagnosis

The viruses responsible for COVID-19, influenza (Influenza A & B), and bronchiolitis (generally caused by RSV) elicit very similar symptoms: cough, fever, fatigue, nasal congestion, respiratory distress, etc. Consequently, it is virtually impossible to determine visually which virus is responsible, especially during the winter season when these viruses co-circulate.

Instead of performing three separate tests, the Toda Covdiag® X Triplex allows you to:

  • Saving time (results for all 3 viruses in 15 minutes)
  • Reducing patient discomfort (only one nasal swab is required)
  • Limiting costs and consumable usage
  • Improving immediate patient management (guidance, isolation, treatment)

Furthermore, the test detects co-infections, meaning the simultaneous presence of multiple viruses, which can occur in children or elderly individuals and may exacerbate the illness.

Thus, it is a rapid, efficient, and comprehensive triage tool, particularly valuable in emergency departments, pediatrics, community medicine, or communal settings (nursing homes, nurseries, hospitals).

Yes, it is entirely possible to be simultaneously infected by multiple respiratory viruses, such as COVID-19 and influenza. This phenomenon is referred to as a co-infection.

Co-infections are particularly common among:

  • Young children, whose immune systems are still immature
  • Elderly or immunocompromised individuals
  • Hospitalized or institutionalized patients, who are exposed to multiple viruses simultaneously

Having multiple viruses simultaneously can make symptoms more severe, complicate diagnosis, and increase the risk of respiratory complications, especially in vulnerable individuals.

Yes, the Toda Covdiag® X Triplex test is designed to detect the presence of viruses even in cases of mild symptoms or during the early stages of infection. It works by detecting viral antigens—that is, proteins produced by viruses as they multiply in the respiratory tract.

This means the test is generally more reliable when the viral load is sufficient, which is often the case in the first few days after symptom onset, even if symptoms are mild (e.g., fatigue, slight fever, mild cough).

Complementary diagnostics in this range

Discover the full range

Need information, training, or a quote?

Tell us what you are looking for, and we will promptly provide a tailored solution.

Contact us
Back to Top